Cancer Survivorship Seminar Series: Onco-Cardiology
Thursday, January 30, 2020
12:00 PM - 1:00 PM
LEARNING OBJECTIVES:
1. Describe incidence, pathophysiology and clinical presentation of anthracycline induced cardiomyopathy.
2. Discuss methods of primary prevention of anthracycline induced cardiomyopathy.
3. Discuss evidence for secondary prevention of anthracycline induced cardiomyopathy.
SPEAKER:
Christopher Gans, MD, FACC
Echocardiography Lab Medical Director
Director of Onco-Cardiology
Division of CardiologyDepartment of Internal Medicine
UI Health
Lunch will be provided